LC-MS/MS is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Common internet and media name. |
| Research code | GW501516 | Also written GW-1516. |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator. |
| Development status | Discontinued | Clinical development halted after rodent cancer findings. |
| Regulatory status | Prohibited in sport | Listed by WADA; not approved as medicine. |
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
== Impact on victims == Corrective rape and other accompanying acts of violence can result in physical and psychological trauma, mutilation, unwanted pregnancy, and may contribute to suicide. Corrective rape is a major contributor to HIV infection in South African lesbians. In South Africa, approximately 10% of lesbians are HIV positive, with corrective rape being the most likely cause. HIV in South Africa is an epidemic, and due to homophobia, there is a lack of education about sexually transmitted diseases among lesbians. Homophobic laws and discrimination in South Africa contribute to the poor quality of health care for minorities. The psychological effects of corrective rape on victims can be detrimental. Many victims in countries such as South Africa and India where corrective rape is most prevalent suffer from a strong sense of insecurity and disempowerment due to strong homophobia in their communities. However, violence against the LGBTQ community in South Africa is seldom reported. Many survivors of corrective rape suffer from triple discrimination for being women, Black, and homosexual. This is especially true in South African townships, where corrective rape is common for lesbian women. Corrective rape victims may suffer from depression, anxiety, and/or post-traumatic stress disorder. Due to racial and sexual discrimination in health care, victims must often deal with these issues on their own.
polymerization The formation of a polymer from its constituent monomers; the chemical reaction or series of reactions by which monomeric subunits are covalently linked together into a polymeric chain or branching aggregate; e.g. the polymerization of a nucleic acid chain by linking consecutive nucleotides, a reaction catalyzed by a polymerase enzyme.
A general synthetic route to organomercury compounds entails alkylation with Grignard reagents and organolithium compounds. Diethylmercury results from the reaction of mercury chloride with two equivalents of ethylmagnesium bromide, a conversion typically conducted in diethyl ether solution. Similarly, diphenylmercury can be prepared by reaction of mercury chloride and phenylmagnesium bromide. A related preparation entails formation of phenylsodium in the presence of mercury(II) salts. Hg(II) can be alkylated by treatment with diazonium salts in the presence of copper metal. In this way 2-chloromercuri-naphthalene has been prepared. 4-Chloromercuritoluene is obtained by the chloromercuration of sodium toluenesulfinite:
Sources: en.wikipedia.org
Russia under Putin has reverted to Tsarism." Ferguson wrote that this Cold War is different from the original Cold War because the US "is so intertwined with China" at the point where "decoupling" is as others argued "a delusion" and because "America's traditional allies are much less eager to align themselves with Washington and against Beijing". He further wrote that the new Cold War "shifted away from trade to technology" when both the US and China signed their Phase One trade deal. In a February 2020 interview with The Japan Times, Ferguson suggested that, to "contain China", the US "work intelligently with its Asian and European allies", as the US had done in the original Cold War, rather than on its own and perform something more effective than "tariffs, which are a very blunt instrument". He also said that the US under Trump has been "rather poor" at making foreign relations. On 24 May 2020, Chinese Foreign Minister Wang Yi said that relations with the US were on the "brink of a new Cold War" after it was fueled by tensions over the COVID-19 pandemic. In June 2020, Boston College political scientist Robert S. Ross wrote that the US and China "are destined to compete [but] not destined for violent conflict or a cold war". In July, Ross said that the Trump "administration would like to fully decouple from China.
=== Argentina === The Armed Forces of the Argentine Republic's combat ration (Spanish: Ración de Combate (Individual)) was introduced in 2003, consisting of a gray plastic-foil laminate pouch containing a mix of canned and dehydrated foods, plus minimal supplements, for one soldier for one day. All products in the RC are domestically produced, commercially available items. Each ration contains canned meat, small can of meat spread, crackers, instant soup, cereal bar with fruit, a chocolate bar with nuts or caramels, instant coffee, orange juice powder, sugar, salt, a heating kit with disposable stove and alcohol-based fuel tablets, disposable butane lighter, resealable plastic bag, cooked rice, and a pack of paper tissues. Menu #1 contains corned beef, meat pâté, crisp water crackers, and instant soup with fideo pasta. Menu #2 contains roasted beef in gravy, meat pâté, whole wheat crackers, and quick-cooking polenta in cheese sauce.
Natural dried, not calcinated diatomaceous earth is regularly used in livestock nutrition research as a source of acid-insoluble ash (AIA), which is used as an indigestible marker. By measuring the content of AIA relative to nutrients in test diets and feces or digesta sampled from the terminal ileum (last third of the small intestine) the percentage of that nutrient digested can be calculated using the following equation:
Sources: en.wikipedia.org
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.
Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.
No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.